Scott Larson

Scott Larson is an Executive Director of National Accounts at Exelixis, where responsibilities have been held since January 2016. Previously, Scott served in various roles within the pharmaceutical sector, including Director of Regional Accounts at AstraZeneca and Director of National Accounts at both Amylin Pharmaceuticals and Genentech. Experience also includes working as Executive Director of Managed Care at Merck/Schering-Plough Pharmaceuticals and Senior Director of Managed Markets at Schering-Plough. Scott holds a Bachelor of Pharmacy and an MBA in Business Administration and Management from Drake University.